U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Monoclonal antibody 1C7 against Chaetomium globosum enolase

Public Domain


Details

  • Personal Author:
    Green, Brett J.
  • Description:
    Method of Immunization: Three 5- to 7-week-old female BALB/cJ mice were immunized via intraperitoneal (IP) injection with a 50:50 (v/v) emulsion of 25 mg of the purified recombinant C. globosum enolase protein and TiterMax Gold Adjuvant. Five subsequent booster IP immunizations containing 5 mg recombinant C. globosum enolase in sterile PBS were administered at biweekly intervals. The final boost was administered 3 days before the monoclonal antibody fusion. Parental Cell Line Used for Fusion: SP2/0-AG14 myeloma cells (ATCC# CRL-1581). Selection and Cloning Procedure: Individual spleens were aseptically removed from each mouse and single cell suspensions of the splenocytes produced. Fusion of splenocytes with SP2/0-AG14 myeloma cells was performed as previously described, and hybridoma cells were cultivated in Dulbecco's Modified Eagle Medium. The supernatant fluid from confluent hybridomas was diluted 1:2 (v/v) in PBS 0.05% Tween-20 containing 3% non-fat dry skim milk powder and tested using a recombinant C. globosum enolase indirect ELISA. Hybridomas that were confirmed to produce recombinant C. globosum enolasespecific MAb were selected, grown in bulk, and then transferred to a 96-well tissue culture plate and cloned twice by limiting dilution. Single positive clones were rescreened using the indirect ELISA, selected, grown in bulk, and purified according to the method of Kent.(3) Heavy and Light Chains of Immunoglobulin: An MAb isotype ELISA was used to identify the isotype of the screened MAb. MAb 1C7 was identified to be IgG1 isotype. Specificity: MAb 1C7 exhibited reactivity to immobilized recombinant C. globosum enolase in an indirect screening ELISA. The IgG1 isotype MAb was then further assessed in SDS-PAGE and Western blot studies. MAb 1C7 bound to immobilized recombinant C. globosum enolase in Western blotting. Additional Western blot studies were designed to evaluate the reactivity of MAb 1C7 to C. globosum protein extract fractions, including spore wash, homogenized spore, and mycelial extracts. The highest MAb 1C7 reactivity was observed to a *49 kDa band in the homogenized spore extract that corresponded to recombinant C. globosum enolase. In crossreactivity studies, the greatest MAb 1C7 reactivity was observed to C. globosum UAMH strains 9683 and 841 as well as a putative enolase derived from C. atrobrunneum. Interestingly, MAb 1C7 did not react with enolase derived from C. indicum or Aspergillus fumigatus. Divergence with as few as two amino acids in the A. fumigatus enolase extract resulted in the loss of MAb reactivity. Based on these data, MAb 1C7 may additionally react with other closely related species within the fungal orders Sordariales and Hypocreales. Specific Antigen Identified: Epitope mapping of MAb 1C7 demonstrated binding to the C. globosum enolase decapeptide, LTYEELANLY. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    2167-9436
  • Document Type:
    Text
  • Genre:
    Journal Article
  • Place as Subject:
  • CIO:
    National Institute for Occupational Safety and Health (NIOSH)
  • Division:
    HELD - Health Effects Laboratory Division
  • Topic:
    Workplace Safety & Health
  • Location:
    North America
  • Volume:
    33
  • Issue:
    5
  • NIOSHTIC Number:
    nn:20045560
  • Citation:
    Monoclon Antib Immunodiagn Immunother 2014 Sep; 33(5):367
  • Contact Point Address:
    Dr. Brett James Green, Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505
  • Email:
    dox6@cdc.gov
  • Federal Fiscal Year:
    2014
  • NORA Priority Area:
    Healthcare and Social Assistance
  • Peer Reviewed:
    True
  • Source Full Name:
    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:bc1e2c0db4e6886a6c61147379240abfe4b140b25eecb4017a666df3d49aa96c6502589ce33083d669bcfbbe86f53635c221acdfc5a08bd8b8a2cb0202beee75
  • Download URL:
  • File Type:
    Filetype[PDF - 34.70 KB ]
PREVIOUS
ON THIS PAGE
Details
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP